Burak KATİPOGLU, Togay EVRİN

Evaluation of hematological parameters in migraine attack in emergency room

Aim: Migraine headaches are one of the serious complaints of patients seeking emergency department (ED) with symptoms of manyhealth problems. In this study, we aimed to examine predictive values of hematological parameters on chronic migraine.Material and Methods: The files of patients admitted to ED of Ufuk University Hospital between January 2016 and November 2016with a headache and who underwent hematological analyses at emergency admission were analyzed retrospectively. After exclusioncriteria were applied, 55 patients with migraine attacks who were previously diagnosed with migraine by a neurologist included inthis study.Results: There was not a statistically significant difference between age and sex distribution of groups (p>0.05), whereas astatistically significant difference was found for family history between patient and control groups (p

PDF

___

1. Friedman D, Feldon S, Holloway R, et al. Utilization, diagnosis, treatment and cost of migraine treatment in the emergency department. Headache 2009;49:1163-73.
2. (Malone CD, Bhowmick A, Wachholtz AB. Migraine: treatments, comorbidities, and quality of life, in the USA. J Pain Res 2015;12:537-47.
3. Miller JA, Missmer SA, Vitonis AF, et al. Prevalence of migraines in adolescents with endometri-osis. Fertil Steril 2018;109:685-90.
4. Romero-Reyes M, Uyanik JM. Orofacial pain management: current perspectives. J Pain Res 2014;21: 99-115.
5. Narain S, Al-Khoury L, Chang E. Resolution of chronic migraine headaches with intrathecal zi-conotide: a case report. J Pain Res 2015;8:603-6.
6. Cerritelli F, Lacorte E, Ruffini N, et al. Osteopathy for primary headache patients: a systematic review. J Pain Res 2017;14:601-11.
7. Davis JA, Robinson RL, Le TK, et al. Incidence and impact of pain conditions and comorbid illnesses. J Pain Res 2011;4:331-45.
8. Negro A, Koverech A, Martelletti P. Serotonin receptor agonists in the acute treatment of mi-graine: a review on their therapeutic potential. J Pain Res 2018;8:515-26.
9. Vandenbussche N, Laterza D, Lisicki M, et al. Medicationoveruse headache: a widely recog-nized entity amidst ongoing debate. J Headache Pain 2018;13:50.
10. Peng X, Sun P, Novick D, et al. Real-world comparison of health care utilization between duloxe-tine and pregabalin initiators with fibromyalgia. J Pain Res 2014;9:37-46.
11. Aamodt AH, Borch-Iohnsen B, Hagen K, et al. Headache prevalence related to Haemoglobin and ferritin. The HUNT Study. Cephalalgia 2004;24:758-62.
12. Headache Classification Committee of the International Headache S. The International Classifi-cation of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013;33:629-808.
13. Coenders A, Chapman C, Hannaford P, et al. In search of risk factors for chronic pain in adoles-cents: a case-control study of childhood and parental associations. J Pain Res 2014;7:175-83.
14. Zencirci B. Comparison of the effects of dietary factors in the management and prophylaxis of migraine. J Pain Res 2010;23:125-30.
15. Stanzani Maserati M. Migraine attacks, aura, and polycythemia: a vasculoneural pathogenesis? J Neural Transm (Vienna) 2011;118:545-7.
16. Lippi G, Cervellin G, Mattiuzzi C. Migraine and erythrocyte biology: a review. Int J Lab Hematol 2014;36:591-7.